{"url":"https://lda.gov/api/v1/filings/dfee5b09-1efd-447b-a322-41d04ebe5cd7/","filing_uuid":"dfee5b09-1efd-447b-a322-41d04ebe5cd7","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/dfee5b09-1efd-447b-a322-41d04ebe5cd7/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Edward B Stewart","dt_posted":"2025-04-18T17:11:33-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1333 H Street NW","registrant_address_2":"Eighth Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104254,"url":"https://lda.gov/api/v1/registrants/401104254/","house_registrant_id":43449,"name":"NOVEL STRATEGIES (FKA) PRISM GROUP","description":"A public affairs and government relations firm.","address_1":"1331 Pennsylvania Avenue, NW","address_2":"Suite 400 South","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"EDWARD STEWART","contact_telephone":"+1 202-683-4079","dt_updated":"2026-04-17T16:41:47.330027-04:00"},"client":{"id":64680,"url":"https://lda.gov/api/v1/clients/64680/","client_id":64680,"name":"THE ALLIANCE FOR LONGEVITY INITIATIVES","general_description":"Advancing policies to increase a healthy human lifespan.","client_government_entity":null,"client_self_select":false,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Directing the Food and Drug Administration to create a pathway for longevity treatment. Reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148918,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"GUY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Increased funding for longevity research at the National Institutes of Health","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148918,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"GUY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}